Internal Medicine, Gastroenterology · Thibodaux, LA
NPI
1023152063
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1107 Audubon Ave A
Thibodaux, LA, 70301
Phone (985) 447-7004
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
751 services
Medicare patients, 2024
297
Average age 73
Drug cost, 2024
$191K
1,923 prescriptions
Company payments, 2025
$287
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pasam S Rao was code 99213 (office e&m - established), 298 times for 184 patients. In total Pasam S Rao billed 751 services in 26 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 298 | 184 | $49.96 | $15K |
| 99214 Office E&M - Established | Office | 124 | 107 | $83.20 | $10K |
| 99232 Hospital E&M - Subsequent | Facility | 104 | 46 | $55.38 | $5,760 |
| 99222 Hospital E&M - Initial | Facility | 46 | 45 | $88.56 | $4,074 |
| 99204 Office E&M - New | Office | 38 | 38 | $92.87 | $3,529 |
| 45384 Colonoscopy - Lesion Removal | Facility | 33 | 33 | $116.36 | $3,840 |
| 43239 Upper GI Endoscopy | Facility | 30 | 30 | $86.69 | $2,601 |
By year: 2022 $91K for 1,240 services; 2023 $68K for 932 services; 2024 $53K for 751 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pasam S Rao prescribed most often to Medicare patients was Famotidine, with 309 prescriptions and refills. In total Pasam S Rao wrote 1,923 Medicare prescriptions that cost $191K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 309 | 528 | 73 | $4,478 |
| Pantoprazole Sodium Generic | 266 | 619 | 82 | $2,037 |
| Sucralfate Generic | 245 | 351 | 64 | $8,950 |
| Omeprazole Generic | 172 | 425 | 49 | $2,625 |
| Lactulose Generic | 130 | 135 | 45 | $1,035 |
| Mesalamine Er Mesalamine | 99 | 135 | 21 | $9,386 |
| Linzess Linaclotide | 99 | 185 | 36 | $100K |
| Balsalazide Disodium Generic | 72 | 102 | 14 | $5,837 |
| Colestipol Hcl Generic | 62 | 107 | 19 | $5,041 |
| Dicyclomine Hcl Generic | 51 | 68 | 14 | $522 |
| Constulose Lactulose | 41 | 41 | 21 | $463 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 34 | 34 | 33 | $2,157 |
| Ondansetron Odt Ondansetron | 30 | 30 | Under 11 | $495 |
| Apriso Mesalamine | 25 | 25 | Under 11 | $12K |
| Rabeprazole Sodium Generic | 23 | 45 | Under 11 | $373 |
Brand drugs: - claims; generic drugs: 1,686 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pasam S Rao $287 ($287 in general payments such as food, travel and fees) from 8 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $75.61.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.